Analysts are nudging their price framework for Surgery Partners, keeping fair value steady at about $25.73 per share while modestly lifting the discount rate from roughly 8.33% to around 8.52% as near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback